Sten Scheibye is a cand.scient. in chemistry and Ph.D. in organic chemistry from the University of Aarhus and an HD in marketing from Copenhagen Business School (CBS).
Sten Scheibye’s career started at Leo Pharma (formerly The Lion’s Chemical Factory) from 1981 to 1993 – most recently as Executive Vice President with responsibility for sales and marketing of pharmaceuticals. From 1995-2008 he was CEO of Coloplast.
Sten Scheibye also has an impressive board career including: former chairman of Novo Nordisk A/S and the Novo Nordisk Foundation as well as Novo Holdings in the period 2003-2018. Furthermore, former Chairman of DTU and the Danish Trade Council 2009 – 2013. In addition, board positions in e.g. Magasin (1997-2002), Danisco (1999-2002), Danske Bank (1998-2011).
Today, Sten Scheibye is chairman of the board at Industriens Fond, Knud Højgaards Fond and BioInnovation Institute and on the board of Fondenes Videncenter. As well as senior advisor for Novo Holdings and member of the board of ConvaTec plc.
Sten Scheibye gives lectures and workshops on board management. He also wants to spend his time and experience as a mentor and master teacher for new and current leaders.